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Identity 
Other names: MAP-4; MGC8617 
HGNC (Hugo): MAP4 
Location: 3p21.31 
 
MAP4 gene (3p21). FISH on normal lymphocytes using the 
BAC clone 395P16 on 3p21 obtained from the RPCI-11 library 
(Roswell Park Cancer Institute, Buffalo, NY). BAC 395P16 
contains sequences derived immediately downstream of the 
MAP4 gene and is translocated to the partner chromosome in 
case of a translocation involving MAP4. 
DNA/RNA 
Description 
MAP4 is encoded by a single-copy gene spanning a 
region of ~238 kb of genomic DNA. Five alternative 
transcripts have been described (West et al., 1991). 
MAP4 is down-regulated by P53 at the transcriptional 
level. The repression of MAP4 by P53 is exerted by  
 
interaction with the promoter region of MAP4.  
Overexpression of MAP4 markedly inhibits P53 
mediated apoptosis (Murphy et al., 1996; Murphy et al., 
1999). 
Transcription 
Centromere to telomere transcription. The multiple 
MAP4 isoforms are generated by alternative splicing 
(see figure below). 
Protein 
Description 
The protein encoded by the MAP4 gene is the major 
microtubule-associated protein in non-neuronal tissue  
and belongs to the group of microtubule-associated 
proteins (MAPs) of the MAP2/Tau family (Bulinski et
al., 1980; Chapin et al., 1995). MAP4 contains a 
projection domain in its extreme N-terminus and a 
microtubule binding domain (MTB) in its carboxyl-
terminal portion. The MTB domain consists of 3 
subdomains, a Proline-rich region, a Repeat region 
consisting of an Assembly-Promoting (AP) sequence of 
18-amino acids (Aas) residues, and a Tail region rich in 
hydophobic and acidic Aas. Three to five repeats of the 
AP sequence have been described in MAP4 (Aizawa et 
al., 1990). In vitro experiments with bovine MAP4 
have shown that the number of repeat sequences affects 
the microtubule surface properties (Tokuraku et al.,
2003). 
Expression 
Widespread tissue distribution but absent from neurons 
(Bulinski and Borisy, 1980; Aizawa et al., 1990; 
Chapin and Bulinski, 1991; West et al., 1991). 
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mRNA splice variants of MAP4. Nucleotide assignation according to GenBank sequence NT_022517 REGION: 
47832180..48070769 GPS_000125239 (Homo sapiens chromosome 3 genomic contig, GRCh37 reference primary 
assembly). 
 





MAP4 binds to, polymerizes, and stabilizes 
microtubules and is thought to regulate microtubule 
dynamics during the cell cycle. In eukaryotic cells, the 
onset of M phase is regulated by the p34cdc2/Cyclin B 
complex, which controls changes in microtubule 
dynamic properties at the G2 to M phase transition of 
the cell cycle The control of the microtubule 
reorganization at mitosis is supposed to be directly 
regulated by phosphorylation of MAP4 by the p34cdc2 
kinase activity (Ookata et al., 1997). 
Homology 
About 80% similarity/70% identity among the human, 
mouse, and bovine Aas sequences (West et al., 1991). 
Implicated in 
Diffuse large B-cell non-Hodgkin's 






Rearrangements of the MALT1 gene by the 
translocations t(11;18)(q21;q21)/API2-MALT1 and 
t(14;18)(q32;q21)/IGH-MALT1 are the most frequent 
structural chromosomal abnormalities in MALT 
lymphomas and lead to an activation of the NF-kB 
pathway (Dierlamm et al., 1999; Uren et al., 2000; 
Lucas et al., 2001; Streubel et al., 2003). In both 
translocations the caspase-like domain of MALT1 is 
invariabily involved.  
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Schematic representation of the localization of the breakpoints in MALT1 and MAP4 and the corresponding fusion product. 
 
Unlike the API2-MALT1 and IGH-MALT1 products, 
the MALT1-MAP4 fusion product does not involve the 
caspase-like domain, which is essential for activation of 
NF-kB. The absence of the caspase like domain in the 
MALT1-MAP4 fusion product distinguishes this novel 
gene fusion, MALT1-MAP4, from the t(11;18)/API2-
MALT1 and the t(14;18)/IGH-MALT1 and points to a 
new mechanism of deregulation of MALT1 (Murga 
Penas et al., 2006). 
Hybrid/Mutated gene 
The 5'MALT1-3'MAP4 fusion product is the result of 
an unbalanced translocation that fuses "in frame" th  
exon 9 of MALT1 located on 18q21 to exon 9 of 
MAP4 located on 3p21 (Murga Penas et al., 2006). The 
MALT1-MAP4 fusion is located on the derivative 
chromosome 18 and due to a partial deletion of 
MALT1 sequences telomeric to exon 9 the reciprocal 
transcript MAP4-MALT1 is absent.  
The MALT1-MAP4 chimeric product corresponds to a 
fusion of the MALT1 gene at nucleotide 1276 
(Genebank Accession No. NM_006785) to the MAP4 
gene at nucleotide 2469 (Genebank Accession No. 
NM_002375). 
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